Answer
Oct 23, 2025 - 11:05 AM
Clinical trials use a dose-escalation protocol, starting at 0.25 mg weekly and increasing to 2.4 mg weekly by week 17. Dose escalation allows the body to adjust gradually, reducing side effects.
Do you have the same question? Follow this Question
Oct 23, 2025 - 11:05 AM
View all Cagrilintide Questions & Answers